133 related articles for article (PubMed ID: 7688627)
1. Value of serum beta 2 microglobulin as an indicator of early relapse in diffuse large cell lymphoma.
Avilés A; Narváez BR; Díaz-Maqueo JC; Guzmán R; Talavera A; García EL
Leuk Lymphoma; 1993 Mar; 9(4-5):377-80. PubMed ID: 7688627
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors for central nervous system involvement in non-Hodgkin's lymphoma: significance of very high serum LDH concentrations.
Tomita N; Kodama F; Sakai R; Koharasawa H; Hattori M; Taguchi J; Fujita H; Tanabe J; Fujisawa S; Fukawa H; Harano H; Kanamori H; Miyashita H; Matsuzaki M; Ogawa K; Motomura S; Maruta A; Ishigatsubo Y
Leuk Lymphoma; 2000 Jul; 38(3-4):335-43. PubMed ID: 10830740
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis.
Cortes JE; Talpaz M; Cabanillas F; Seymour JF; Kurzrock R
Blood; 1995 May; 85(9):2516-20. PubMed ID: 7537119
[TBL] [Abstract][Full Text] [Related]
4. Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B.
Lee AY; Connors JM; Klimo P; O'Reilly SE; Gascoyne RD
J Clin Oncol; 1997 May; 15(5):1745-53. PubMed ID: 9164181
[TBL] [Abstract][Full Text] [Related]
5. The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen.
Shipp MA; Yeap BY; Harrington DP; Klatt MM; Pinkus GS; Jochelson MS; Rosenthal DS; Skarin AT; Canellos GP
J Clin Oncol; 1990 Jan; 8(1):84-93. PubMed ID: 1688615
[TBL] [Abstract][Full Text] [Related]
6. Prognostic models for diffuse large B-cell lymphoma.
Conconi A; Zucca E; Roggero E; Bertoni F; Bernasconi A; Mingrone W; Pedrinis E; Cavalli F
Hematol Oncol; 2000 Jun; 18(2):61-73. PubMed ID: 10960876
[TBL] [Abstract][Full Text] [Related]
7. Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission.
Weeks JC; Yeap BY; Canellos GP; Shipp MA
J Clin Oncol; 1991 Jul; 9(7):1196-203. PubMed ID: 1710656
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of primary mediastinal large B-cell lymphomas].
Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
[TBL] [Abstract][Full Text] [Related]
9. Prognostic markers in diffuse large B-cell lymphoma: Keys to the underlying biology.
Winter JN
Curr Hematol Malig Rep; 2007 Oct; 2(4):235-41. PubMed ID: 20425375
[TBL] [Abstract][Full Text] [Related]
10. m-BACOD treatment for intermediate- and high-grade malignant lymphomas: a Southwest Oncology Group phase II trial.
Dana BW; Dahlberg S; Miller TP; Hartsock RJ; Balcerzak S; Coltman CA; Carden JO; Hartley K; Fisher RI
J Clin Oncol; 1990 Jul; 8(7):1155-62. PubMed ID: 1694233
[TBL] [Abstract][Full Text] [Related]
11. Beta 2 microglobulin level as an indicator of prognosis in diffuse large cell lymphoma.
Avilés A; Zepeda G; Díaz-Maqueo JC; Rodriguez L; Guzmán R; García EL; Talavera A
Leuk Lymphoma; 1992 May; 7(1-2):135-8. PubMed ID: 1472924
[TBL] [Abstract][Full Text] [Related]
12. Elevated lactate dehydrogenase levels detected during routine follow-up do not predict relapse in patients with diffuse large B-cell lymphoma who achieve complete remission after primary treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-like immunochemotherapy.
El-Sharkawi D; Basu S; Ocampo C; Qian W; D'Sa S; Hoskin PJ; Ardeshna KM
Leuk Lymphoma; 2012 Oct; 53(10):1949-52. PubMed ID: 22462615
[TBL] [Abstract][Full Text] [Related]
13. A follow-up of a randomized study comparing two chemotherapy treatments for advanced diffuse histiocytic lymphoma.
Todd M; Cadman E; Spiro P; Bertino J; Farber L; Waldron J; Fischer D
J Clin Oncol; 1984 Sep; 2(9):986-93. PubMed ID: 6206207
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era.
Seo S; Hong JY; Yoon S; Yoo C; Park JH; Lee JB; Park CS; Huh J; Lee Y; Kim KW; Ryu JS; Kim SJ; Kim WS; Yoon DH; Suh C
Oncotarget; 2016 Nov; 7(47):76934-76943. PubMed ID: 27764777
[TBL] [Abstract][Full Text] [Related]
15. [M-BACOD in advanced case of non-Hodgkin's lymphoma].
Itami J; Ogata H; Shimizu K; Nemoto K; Yasuda S; Yoshida H; Mikata A; Arimizu N
Gan No Rinsho; 1990 Mar; 36(4):499-504. PubMed ID: 1690824
[TBL] [Abstract][Full Text] [Related]
16. [Central nervous system relapse in diffuse large B cell lymphoma: Risk factors].
Sancho JM; Ribera JM;
Med Clin (Barc); 2016 Jan; 146(2):74-80. PubMed ID: 25817451
[TBL] [Abstract][Full Text] [Related]
17. The response of diffuse large cell and other intermediate grade non-Hodgkin's lymphomas to adriamycin containing combination chemotherapy.
Lishner M; Slingerland J; Theresa C; Sutcliffe SB
Leuk Lymphoma; 1994 Mar; 13(1-2):131-6. PubMed ID: 7517744
[TBL] [Abstract][Full Text] [Related]
18. Diffuse large-cell lymphoma of the testis.
Tondini C; Ferreri AJ; Siracusano L; Valagussa P; Giardini R; Rampinelli I; Bonadonna G
J Clin Oncol; 1999 Sep; 17(9):2854-8. PubMed ID: 10561362
[TBL] [Abstract][Full Text] [Related]
19. Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD).
Skarin AT; Canellos GP; Rosenthal DS; Case DC; MacIntyre JM; Pinkus GS; Moloney WC; Frei E
J Clin Oncol; 1983 Feb; 1(2):91-8. PubMed ID: 6199472
[TBL] [Abstract][Full Text] [Related]
20. Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase.
Rodriguez J; Pugh WC; Romaguera JE; Luthra R; Hagemeister FB; McLaughlin P; Rodriguez MA; Swan F; Cabanillas F
Ann Oncol; 1994 Nov; 5(9):847-9. PubMed ID: 7848887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
